UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance

HIV medicine, 2014-04, Vol.15 (4), p.193-195

2014

Volltextzugriff (PDF)

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Open forum infectious diseases, 2022-03, Vol.9 (3), p.ofab595-ofab595

2022

Volltextzugriff (PDF)

Hill A, Moyle G. Relative antiviral efficacy of ritonavir‐boosted darunavir and ritonavir‐boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259–264

HIV medicine, 2007-11, Vol.8 (8), p.568-570

2007

Volltextzugriff (PDF)

Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men

HIV medicine, 2012-10, Vol.13 (9), p.549-557

2012

Volltextzugriff (PDF)

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

Clinical infectious diseases, 2023-08, Vol.77 (4), p.593-605

2023

Volltextzugriff (PDF)

Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy

AIDS (London), 1997-03, Vol.11 (3), p.400-401

1997

Volltextzugriff (PDF)

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

AIDS (London), 2011-09, Vol.25 (14), p.1683-1690

2011

Volltextzugriff (PDF)

Effect of efavirenz versus nevirapine in antiretroviral-naive individuals in the HIV-CAUSAL Collaboration Cohort

AIDS (London), 2012-10, Vol.26 (16), p.2117-2118

2012

Volltextzugriff (PDF)

Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men

Sexually transmitted diseases, 2013-01, Vol.40 (1), p.3-10

2013

Volltextzugriff (PDF)

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

AIDS (London), 2023-01, Vol.37 (1), p.91-103

2023

Volltextzugriff (PDF)

Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

AIDS (London), 2021-05, Vol.35 (6), p.869-882

2021

Volltextzugriff (PDF)

First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better

AIDS reviews, 2009-10, Vol.11 (4), p.215-222

Llibre, Josep M

2009

Volltextzugriff (PDF)

Prevalence of cardiovascular risk factors in Spanish HIV‐1‐infected male inmates

Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.P67-P67

2010

Volltextzugriff (PDF)

Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir

AIDS (London), 2005-09, Vol.19 (13), p.1385-1391

2005

Volltextzugriff (PDF)

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice

Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.P35-P35

2010

Volltextzugriff (PDF)

Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men

Clinical microbiology and infection, 2014-09, Vol.20 (9), p.O585-O589

2014

Volltextzugriff (PDF)

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

Antiviral therapy, 2010, Vol.15 (7), p.959-961

Llibre, Josep M

2010

Volltextzugriff (PDF)

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

AIDS reviews, 2010-07, Vol.12 (3), p.135-148

2010

Volltextzugriff (PDF)

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2194-2194

2011

Volltextzugriff (PDF)

Evaluación inicial de un nuevo diagnóstico de infección por el VIH

Medicine - programa de formación médica continuada acreditado, 2010-06, Vol.10 (59), p.4107.e1-4107.e3

Llibre, J.M

2010

Volltextzugriff (PDF)

Antimicrobial prophylaxis for dental extractions after splenectomy

The Lancet (British edition), 1991-06, Vol.337 (8755), p.1485-1486

1991

Volltextzugriff (PDF)

Silent spontaneous retroperitoneal abscess caused by M-type 18 Streptococcus pyogenes

European journal of clinical microbiology & infectious diseases, 1992-02, Vol.11 (2), p.205

1992

Volltextzugriff (PDF)

Lymphogranuloma venerium proctitis in the setting of HIV: a case report and differential diagnosis

AIDS patient care and STDs, 2009-07, Vol.23 (7), p.493-494

2009

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaHiv

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Hill A, Moyle G. Relative antiviral efficacy of ritonavir‐boosted darunavir and ritonavir‐boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259–264

Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus

Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

Effect of efavirenz versus nevirapine in antiretroviral-naive individuals in the HIV-CAUSAL Collaboration Cohort

Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents

First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better

Prevalence of cardiovascular risk factors in Spanish HIV‐1‐infected male inmates

Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice

Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Evaluación inicial de un nuevo diagnóstico de infección por el VIH

Antimicrobial prophylaxis for dental extractions after splenectomy

Silent spontaneous retroperitoneal abscess caused by M-type 18 Streptococcus pyogenes

Lymphogranuloma venerium proctitis in the setting of HIV: a case report and differential diagnosis

Aktive Filter

Suchergebnisse filtern